I. V. Van Gelder

发表

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

Jeroen J. Bax, A. Camm, E. Aliot, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

A. Camm, P. Kirchhof, G. Lip, 2010, European heart journal.

Risk Factor Management in Atrial Fibrillation.

I. V. Van Gelder, A. Brandes, M. D. Smit, 2018, Arrhythmia & electrophysiology review.

Subclinical atrial fibrillation and the risk of stroke.

A. Capucci, I. V. Van Gelder, C. Lau, 2012, The New England journal of medicine.

Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration

P. Kirchhof, G. Lip, I. V. Van Gelder, 2017, Circulation.

Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad

G. Lip, I. V. Van Gelder, B. Gorenek, 2018 .

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference.

G. Breithardt, A. Camm, P. Kirchhof, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference.

G. Breithardt, A. Camm, E. Aliot, 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.

G. Breithardt, A. Camm, P. Kirchhof, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

P. Kirchhof, G. Lip, U. Schotten, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

P. Kirchhof, G. Lip, U. Schotten, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

A Large Candidate Gene Survey Identifies the KCNE1 D85N Polymorphism as a Possible Modulator of Drug-Induced Torsades de Pointes

Marylyn D. Ritchie, Thomas Meitinger, Dana C. Crawford, 2012, Circulation. Cardiovascular genetics.

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS).

Jeroen J. Bax, G. Lip, I. V. Van Gelder, 2020, European heart journal.

Atrial reverse remodelling is associated with outcome of cardiac resynchronization therapy.

I. V. Van Gelder, M. Rienstra, M. Kloosterman, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation.

Erwan Donal, Gilbert Habib, Roxy Senior, 2016, European heart journal cardiovascular Imaging.

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).

Lluís Mont, Helmut Baumgartner, Christophe Leclercq, 2013, European heart journal.

Depletion of atrial natriuretic peptide during longstanding atrial fibrillation.

I. V. Van Gelder, M. P. van den Berg, D. V. van Veldhuisen, 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

Otto Kamp, Jan G P Tijssen, H. Crijns, 2004, Journal of the American College of Cardiology.

Device-Detected Atrial Fibrillation.

I. V. Van Gelder, M. Rienstra, Michiel Rienstra, 2019, Circulation.

Association between heart failure aetiology and magnitude of echocardiographic remodelling and outcome of cardiac resynchronization therapy

I. V. Van Gelder, M. Rienstra, F. Prinzen, 2020, ESC heart failure.

Rate control drugs differ in the prevention of progression of atrial fibrillation

H. Crijns, I. V. Van Gelder, M. Rienstra, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.

I. V. Van Gelder, A. Wilde, M. P. van den Berg, 2007, American heart journal.

Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene.

I. V. Van Gelder, M. P. van den Berg, R. Hofstra, 2009, Heart rhythm.

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial

G. Breithardt, H. Crijns, P. Kirchhof, 2021, European heart journal.

Regional differences in referral, procedures, and outcome after ablation for atrial fibrillation in Europe: a report from the Atrial Fibrillation Ablation Pilot Registry of the European Society of Cardiology.

I. V. Van Gelder, P. Vardas, L. Tavazzi, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysis.

I. V. Van Gelder, S. Yusuf, Á. Avezum, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

I. V. Van Gelder, M. Rienstra, H. Crijns, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Clustering of RR Intervals Predicts Effective Electrical Cardioversion for Atrial Fibrillation

Jaap Haaksma, Jan Brouwer, Harry J G M Crijns, 2004, Journal of cardiovascular electrophysiology.

First-line treatment of persistent and long-standing persistent atrial fibrillation with single-stage hybrid ablation: a 2-year follow-up study

I. V. Van Gelder, M. Rienstra, Y. Blaauw, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Hypertension and cardiac arrhythmias: a consensus document from the European Heart Rhythm Association (EHRA) and ESC Council on Hypertension, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiologí

G. Lip, I. V. Van Gelder, B. Gorenek, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study.

H. Crijns, I. V. Van Gelder, M. Rienstra, 2007, European heart journal.

Desmoglein-2 and Desmocollin-2 Mutations in Dutch Arrhythmogenic Right Ventricular Dysplasia/Cardiomypathy Patients: Results From a Multicenter Study

R. Hauer, I. V. Van Gelder, M. Nelen, 2009, Circulation. Cardiovascular genetics.

Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study.

I. V. Van Gelder, M. Rienstra, J. Tijssen, 2005, American heart journal.

Clinical characteristics of persistent lone atrial fibrillation in the RACE study.

H. Crijns, I. V. Van Gelder, M. Rienstra, 2004, The American journal of cardiology.

Atrial Fibrillation During Cardiac Resynchronization Therapy.

I. V. Van Gelder, M. Rienstra, M. Kloosterman, 2017, Heart failure clinics.

Atrial Fibrillation During Cardiac Resynchronization Therapy.

I. V. Van Gelder, M. Rienstra, M. Kloosterman, 2015, Cardiac electrophysiology clinics.

Prognostic Significance of Atrial Arrhythmias in a Primary Prevention ICD Population

I. V. Van Gelder, B. Wilkoff, U. Birgersdotter-Green, 2011, Pacing and clinical electrophysiology : PACE.

Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time.

I. V. Van Gelder, M. Rienstra, D. V. van Veldhuisen, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria.

M. Allessie, H. Crijns, I. V. Van Gelder, 1999, Circulation.

Sudden Cardiac Death in Adult Congenital Heart Disease

I. V. Van Gelder, A. Zwinderman, B. Mulder, 1996, Circulation.

Cardiac resynchronization therapy in adults with congenital heart disease

I. V. Van Gelder, B. Mulder, C. Silversides, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

UvA-DARE ( Digital Academic Repository ) Efficacy , safety , and determinants of conversion of atrial fibrillation and flutter with oral amiodarone

I C van Gelder, H. Crijns, I. V. Van Gelder, 1997 .

Decrease of right and left atrial sizes after direct-current electrical cardioversion in chronic atrial fibrillation.

I. V. Van Gelder, H. Crijns, K. Lie, 1991, The American journal of cardiology.

The RACE to the EAST. In pursuit of rhythm control therapy for atrial fibrillation-a dedication to Harry Crijns.

G. Breithardt, A. Camm, P. Kirchhof, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation

U. Schotten, I. V. Van Gelder, M. Rienstra, 2017, European heart journal.

Non vitamin K anticoagulation drugs will win the race

I. V. Van Gelder, M. Rienstra, R. D. De With, 2016, Netherlands Heart Journal.

QRS Area Is a Strong Determinant of Outcome in Cardiac Resynchronization Therapy

I. V. Van Gelder, M. Rienstra, F. Prinzen, 2018, Circulation. Arrhythmia and electrophysiology.

Impact of interventricular lead distance and the decrease in septal-to-lateral delay on response to cardiac resynchronization therapy.

I. V. Van Gelder, D. V. van Veldhuisen, A. Maass, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Time to implement fitness and reduction of fatness in atrial fibrillation therapy.

I. V. Van Gelder, M. Rienstra, J. Brügemann, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Importance of Heart Rate During Exercise for Response to Cardiac Resynchronization Therapy

I. V. Van Gelder, D. V. van Veldhuisen, J. Brügemann, 2009, Journal of cardiovascular electrophysiology.

Prognostic significance of changes in heart rate following uptitration of beta-blockers in patients with sub-optimally treated heart failure with reduced ejection fraction in sinus rhythm versus atrial fibrillation

I. V. Van Gelder, P. Ponikowski, M. Rienstra, 2019, Clinical Research in Cardiology.

Heart rate and outcome in heart failure with reduced ejection fraction: Differences between atrial fibrillation and sinus rhythm—A CIBIS II analysis

I. V. Van Gelder, M. Rienstra, D. V. van Veldhuisen, 2017, Clinical cardiology.

Cardiac resynchronisation therapy and the role of optimal device utilisation

I. V. Van Gelder, D. J. Veldhuisen, A. Maass, 2009, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Update on management of atrial fibrillation in heart failure: a focus on ablation

I. V. Van Gelder, M. Rienstra, Y. Blaauw, 2021, Heart.

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure

G. Breithardt, H. Crijns, P. Kirchhof, 2021, Circulation.

Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.

I. V. Van Gelder, M. D. Smit, M. Rienstra, 2007, American heart journal.

Outcome of pharmacological rhythm control for new-onset persistent atrial fibrillation in patients with systolic heart failure: a comparison with patients with normal left ventricular function.

I. V. Van Gelder, M. P. van den Berg, D. V. van Veldhuisen, 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.

I. V. Van Gelder, M. Rienstra, H. Crijns, 2006, European heart journal.

Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.

I. V. Van Gelder, M. D. Smit, M. Rienstra, 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.

I. V. Van Gelder, M. Rienstra, M. P. van den Berg, 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study.

H. Crijns, I. V. Van Gelder, M. Rienstra, 2005, Heart rhythm.

Rising prevalence of atrial fibrillation in the elderly population: new challenges of geriatric cardiology.

I. V. Van Gelder, H. Crijns, M. Kloosterman, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Heart rate increase and inappropriate sinus tachycardia after cryoballoon pulmonary vein isolation for atrial fibrillation

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2021, Netherlands Heart Journal.

Young-onset atrial fibrillation: Sex differences in clinical profile, progression rate and cardiovascular outcome☆

I. V. Van Gelder, M. Rienstra, B. Mulder, 2019, International journal of cardiology. Heart & vasculature.

Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction.

I. V. Van Gelder, H. Crijns, D. V. van Veldhuisen, 2000, Journal of cardiac failure.

Symptomatic but not asymptomatic non-sustained ventricular tachycardia is associated with appropriate implantable cardioverter therapy in tetralogy of Fallot.

I. V. Van Gelder, A. Zwinderman, B. Mulder, 2013, International journal of cardiology.

HSPB1, HSPB6, HSPB7 and HSPB8 Protect against RhoA GTPase-Induced Remodeling in Tachypaced Atrial Myocytes

I. V. Van Gelder, F. Hoogstra-Berends, R. Meijering, 2011, PloS one.

Telomere length and incident atrial fibrillation – data of the PREVEND cohort

I. V. Van Gelder, M. Rienstra, P. van der Harst, 2017, PloS one.

Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study.

I. V. Van Gelder, M. Rienstra, P. van der Harst, 2018, International journal of cardiology.

Upstream therapy of atrial fibrillation

I. V. Van Gelder, M. D. Smit, 2009, Expert review of cardiovascular therapy.

Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients.

I. V. Van Gelder, M. D. Smit, D. V. van Veldhuisen, 2006, Heart rhythm.

A specialized atrial fibrillation clinic: improving care and costs for patients with atrial fibrillation.

I. V. Van Gelder, M. Rienstra, 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Recommendations for pacemaker implantation for the treatment of atrial tachyarrhythmias and resynchronisation therapy for heart failure: A report from the task force on pacemaker indications of the Dutch Working Group on Cardiac Pacing.

L. Jordaens, I. V. Van Gelder, N. V. van Hemel, 2004, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Identification of patients at risk of sudden cardiac death in congenital heart disease. The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease: PREVENTION-ACHD.

I. V. Van Gelder, A. Zwinderman, R. D. de Winter, 2021, Heart rhythm.

Myocardial bridging in a survivor of sudden cardiac near-death: role of intracoronary doppler flow measurements and angiography during dobutamine stress in the clinical evaluation.

H. Crijns, I. V. Van Gelder, H. Crijns, 1997, Heart.

Sudden cardiac death in adult congenital heart disease: can the unpredictable be foreseen?

I. V. Van Gelder, A. Zwinderman, B. Mulder, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

The left atrium: An overlooked prognostic tool

I. V. Van Gelder, M. Rienstra, J. Healey, 2017, European journal of preventive cardiology.

Dyspnea in patients with atrial fibrillation: Mechanisms, assessment and an interdisciplinary and integrated care approach

H. Crijns, I. V. Van Gelder, T. Eijsvogels, 2022, International journal of cardiology. Heart & vasculature.

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

I. V. Van Gelder, H. Crijns, M. P. van den Berg, 2005, BMC cardiovascular disorders.

Ventricular tachyarrhythmia detection by implantable loop recording in patients with heart failure and preserved ejection fraction: the VIP‐HF study

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2020, European journal of heart failure.

Implantable Cardioverter Defibrillator Therapy in Adults With Congenital Heart Disease: Who Is at Risk of Shocks?

I. V. Van Gelder, A. Wilde, B. Mulder, 2012, Circulation. Arrhythmia and electrophysiology.

Pathophysiological pathways in patients with heart failure and atrial fibrillation

I. V. Van Gelder, M. Rienstra, N. Samani, 2021, Cardiovascular research.

PREVENTION-ACHD: PRospEctiVE study on implaNTable cardioverter-defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease; Rationale and Design

I. V. Van Gelder, A. Zwinderman, B. Mulder, 2019, Netherlands Heart Journal.

Atrial fibrillation progression and outcome in patients with young-onset atrial fibrillation

I. V. Van Gelder, M. Rienstra, R. D. De With, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Radiofrequency ablation of atrial fibrillation.

I. V. Van Gelder, H. Crijns, D. V. van Veldhuisen, 2004, International journal of cardiology.

Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation

P. Kirchhof, I. V. Van Gelder, H. Heidbuchel, 2019, European heart journal.

Guidelines for atrial fibrillation in heart failure need to be clarified.

I. V. Van Gelder, M. D. Smit, D. V. van Veldhuisen, 2010, Journal of the American College of Cardiology.

Management of atrial fibrillation in the setting of heart failure.

I. V. Van Gelder, H. Crijns, H. Crijns, 1997, European heart journal.

Rapid Pacing Results in Changes in Atrial But Not in Ventricular Refractoriness

H. Crijns, I. V. Van Gelder, R. Tieleman, 2002, Pacing and clinical electrophysiology : PACE.

Plakophilin-2 Mutations Are the Major Determinant of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

R. Hauer, I. V. Van Gelder, A. Wilde, 2006, Circulation.

Chronic obstructive pulmonary disease and atrial fibrillation: an interdisciplinary perspective.

U. Schotten, I. V. Van Gelder, H. Heidbuchel, 2020, European Heart Journal.

Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women

I. V. Van Gelder, B. Nguyen, M. Rienstra, 2021, PloS one.

Atrial fibrillation: a mechanism or just a bystander?

I. V. Van Gelder, M. D. Smit, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Resumption of anticoagulation after major bleeding decreases the risk of stroke in patients with atrial fibrillation

I. V. Van Gelder, M. D. Smit, 2017, Evidence-Based Medicine.

Sinus node function after cardiac surgery: is impairment specific for the maze procedure?

I. V. Van Gelder, R. Tieleman, A. Smit, 2004, International journal of cardiology.

Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: role of duration of atrial fibrillation.

H. Crijns, I. V. Van Gelder, H. Crijns, 1998, American heart journal.

Atrial Natriuretic Peptides During Experimental Atrial Tachycardia:

H. Crijns, I. V. Van Gelder, M. P. van den Berg, 2004, Journal of cardiovascular electrophysiology.

Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications.

H. Crijns, U. Schotten, I. V. Van Gelder, 2021, Cardiovascular research.

Recurrent and founder mutations in the Netherlands—Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy

J. G. Post, R. Hauer, I. V. Van Gelder, 2013, Netherlands Heart Journal.

AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.

I. V. Van Gelder, M. Rienstra, L. Fauchier, 2021, European heart journal.

Pitfalls of internal cardioverter defibrillator implantation: part II.

I. V. Van Gelder, A. Maass, T. Waterbolk, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Sex differences in catheter ablation of atrial fibrillation: results from AXAFA-AFNET 5

P. Kirchhof, U. Schotten, I. V. Van Gelder, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Aetiology of Heart Failure, Rather than Sex, Determines Reverse LV Remodelling Response to CRT

I. V. Van Gelder, M. Rienstra, K. Vernooy, 2021, Journal of Clinical Medicine.

How to prevent ICD shocks: part I.

I. V. Van Gelder, A. Maass, S. Buck, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

How to prevent ICD shocks: part II.

Rationale and design of the PHOspholamban RElated CArdiomyopathy intervention STudy (i-PHORECAST)

I. V. Van Gelder, H. Tan, R. D. de Boer, 2021, Netherlands Heart Journal.

Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: data from the AF-RISK study.

H. Crijns, U. Schotten, I. V. Van Gelder, 2021, American heart journal.

Troponin I Isoform Expression in Human and Experimental Atrial Fibrillation

M. Allessie, I. V. Van Gelder, G. V. van Eys, 2004, Circulation.

Pleiotropic effects of factor Xa and thrombin: what to expect from novel anticoagulants.

U. Schotten, I. V. Van Gelder, H. Crijns, 2014, Cardiovascular research.

Predictors of ventricular tachyarrhythmia in high-risk myocardial infarction patients treated with primary coronary intervention

I. V. Van Gelder, F. Zijlstra, J. Haaksma, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Rate control drugs differ in the prevention of progression of atrial fibrillation

H. Crijns, I. V. Van Gelder, M. Rienstra, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2021 ESC Guidelines on cardiovascular disease prevention in clinical practice].

I. V. Van Gelder, N. Sattar, S. Tonstad, 2022, Giornale italiano di cardiologia.

The clinical value of regular thyroid function tests during amiodarone treatment.

I. V. Van Gelder, M. Rienstra, S. Benjamens, 2017, European journal of endocrinology.

Electrical cardioversion of atrial fibrillation and atrial flutter: manoeuvres and tips to increase its effectiveness-Authors' reply.

P. Kirchhof, I. V. Van Gelder, A. Brandes, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation.

I. V. Van Gelder, D. V. van Veldhuisen, M. Hemels, 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Spontaneous resolution of left bundle branch block and biventricular stimulation lead to reverse remodeling in dyssynchronopathy.

I. V. Van Gelder, M. Rienstra, M. Kloosterman, 2016, Journal of electrocardiology.

Different circulating biomarkers in women and men with paroxysmal atrial fibrillation: results from the AF-RISK and RACE V studies

H. Crijns, U. Schotten, I. V. Van Gelder, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study

I. V. Van Gelder, M. D. Smit, B. Nguyen, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Beat shock proteins and atrial fibrillation

I. V. Van Gelder, R. Henning, B. Brundel, 2007, Cell stress & chaperones.

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.

G. Breithardt, H. Crijns, P. Kirchhof, 2020, The New England journal of medicine.

Early rhythm-control therapy efficacious in men and women with AF

I. V. Van Gelder, Robert van den Heuvel, 2022, Medicom Conference Report EHRA 2022.

Association between comorbidities and left and right atrial dysfunction in patients with paroxysmal atrial fibrillation: Analysis of AF-RISK.

H. Crijns, U. Schotten, I. V. Van Gelder, 2022, International journal of cardiology.

Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial

H. Crijns, I. V. Van Gelder, M. D. Smit, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Molecular genetic analysis of six Dutch families with atrial fibrillation.

R. Hauer, I. V. Van Gelder, R. Derksen, 2005, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation

U. Schotten, I. V. Van Gelder, B. Nguyen, 2022, Heart.

Relation of overweight and symptomatic atrial fibrillation: A case report

I. V. Van Gelder, M. Rienstra, Gijs E De Maat, 2015, HeartRhythm case reports.

Benefits and risks of antiarrhythmic drug therapy after DC electrical cardioversion of atrial fibrillation or flutter.

I. V. Van Gelder, H. Crijns, K. Lie, 1994, European heart journal.

Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm

H. Crijns, I. V. Van Gelder, J. Ruskin, 2022, Circulation. Arrhythmia and electrophysiology.

Valsartan and recurrent atrial fibrillation.

I. V. Van Gelder, M. D. Smit, 2009, New England Journal of Medicine.

Successful treatment of a patient with symptomatic long QT syndrome type 3 using ranolazine combined with a beta-blocker.

I. V. Van Gelder, M. P. van den Berg, P. Volders, 2014, International journal of cardiology.

Predictors of non-pharmacological intervention in patients with paroxysmal atrial fibrillation: Value of neuroticism.

I. V. Van Gelder, M. P. van den Berg, D. V. van Veldhuisen, 2006, International journal of cardiology.

Will we be able to predict in which atrial fibrillation patients a rhythm control strategy will be successful?

I. V. Van Gelder, M. D. Smit, 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Mobile health adherence for the detection of recurrent recent-onset atrial fibrillation

H. Crijns, I. V. Van Gelder, M. Rienstra, 2022, Heart.

Mobile app-based symptom-rhythm correlation assessment in patients with persistent atrial fibrillation.

I. V. Van Gelder, M. Rienstra, K. Vernooy, 2022, International journal of cardiology.

Prethrombotic State in Young Very Low-Risk Patients With Atrial Fibrillation.

I. V. Van Gelder, M. Rienstra, H. Crijns, 2017, Journal of the American College of Cardiology.

The EAST study: redefining the role of rhythmcontrol therapy in atrial fibrillation: EAST, the Early treatment of Atrial fibrillation for Stroke prevention Trial.

E. Aliot, P. Kirchhof, I. V. Van Gelder, 2015, European heart journal.

Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the MARC study - authors reply.

I. V. Van Gelder, M. Rienstra, K. Vernooy, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Comparison of strain imaging techniques in CRT candidates: CMR tagging, CMR feature tracking and speckle tracking echocardiography

I. V. Van Gelder, M. Rienstra, P. Croisille, 2017, The International Journal of Cardiovascular Imaging.

Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options

G. Breithardt, P. Kirchhof, G. Lip, 2011, Thrombosis and Haemostasis.

Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration.

H. Crijns, P. Kirchhof, G. Lip, 2019, Circulation.

Risk of thromboembolism and bleeding after general surgery in patients with atrial fibrillation.

I. V. Van Gelder, M. Rienstra, H. Crijns, 2005, The American journal of cardiology.

Randomized Trials Fit for the 21st Century. A Joint Opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and the World Heart Federation

M. Landray, R. Collins, P. Kirchhof, 2022, Global heart.

Determinants and outcome of amiodarone‐associated thyroid dysfunction

I. V. Van Gelder, D. V. van Veldhuisen, T. Links, 2011, Clinical endocrinology.

Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation.

I. V. Van Gelder, H. Crijns, R. Henning, 2002, Cardiovascular research.

Integrated care to reduce atrial fibrillation burden: do not underrate the overweight!

I. V. Van Gelder, M. D. Smit, M. Rienstra, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Impact of atrial fibrillation on mortality in patients with chronic heart failure

I. V. Van Gelder, M. P. van den Berg, D. V. van Veldhuisen, 2002, European journal of heart failure.

Ion Channel Remodeling Is Related to Intraoperative Atrial Effective Refractory Periods in Patients With Paroxysmal and Persistent Atrial Fibrillation

H. Crijns, I. V. Van Gelder, R. Tieleman, 2001, Circulation.

Impact of Thoracoscopic Pulmonary Vein Isolation on Right Ventricular Function: A Pilot Study

I. V. Van Gelder, O. Alfieri, M. Rienstra, 2018, BioMed research international.

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

I. V. Van Gelder, B. Lewis, L. Fauchier, 2021, European heart journal.

Multi-ethnic genome-wide association study for atrial fibrillation

Jay A. Montgomery, Nathan A. Bihlmeyer, Henry J. Lin, 2018, Nature Genetics.

Long-term results of surgical minimally invasive pulmonary vein isolation for paroxysmal lone atrial fibrillation.

I. V. Van Gelder, O. Alfieri, S. Benussi, 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Feasibility and outcome of epicardial pulmonary vein isolation for lone atrial fibrillation using minimal invasive surgery and high intensity focused ultrasound.

I. V. Van Gelder, A. ten Hagen, F. Zijlstra, 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.

H. Crijns, I. V. Van Gelder, M. Rienstra, 2008, JAMA.

Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation.

I. V. Van Gelder, M. Rienstra, B. Schoonderwoerd, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Who, when and how to rate control for atrial fibrillation

I. V. Van Gelder, M. Rienstra, 2008, Current opinion in cardiology.

Heat shock protein upregulation protects against pacing-induced myolysis in HL-1 atrial myocytes and in human atrial fibrillation.

I. V. Van Gelder, H. Crijns, R. Henning, 2006, Journal of molecular and cellular cardiology.

Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries: The RE-LY Atrial Fibrillation Registry

I. V. Van Gelder, S. Yusuf, Jun Zhu, 2014, Circulation.

Ethnic Differences in Atrial Fibrillation Identified Using Implanted Cardiac Devices

A. Capucci, I. V. Van Gelder, C. Lau, 2013, Journal of cardiovascular electrophysiology.

New risk factors for atrial fibrillation: causes of 'not-so-lone atrial fibrillation'.

I. V. Van Gelder, M. D. Smit, B. Schoonderwoerd, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society

G. Lip, S. Ernst, I. V. Van Gelder, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation.

I. V. Van Gelder, D. V. van Veldhuisen, W. V. van Gilst, 2011, Cardiovascular research.

Relation of renal dysfunction with incident atrial fibrillation and cardiovascular morbidity and mortality: The PREVEND study

I. V. Van Gelder, M. Rienstra, P. van der Harst, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.

H. Crijns, I. V. Van Gelder, J. Tijssen, 2011, Journal of the American College of Cardiology.

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

Steffen E. Petersen, O. Franco, I. V. Van Gelder, 2016, European journal of preventive cardiology.

Genetic risk and atrial fibrillation in patients with heart failure

I. V. Van Gelder, P. Ponikowski, M. Rienstra, 2020, European journal of heart failure.

Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop.

M. Link, D. Singer, I. V. Van Gelder, 2021, Circulation.

Atrial fibrillation: villain or bystander in vascular brain injury

I. V. Van Gelder, B. Freedman, H. Kamel, 2020, European heart journal supplements : journal of the European Society of Cardiology.

Quality indicators for the care and outcomes of adults with atrial fibrillation.

I. V. Van Gelder, G. Hindricks, A. Bollmann, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

The 4S-AF Scheme (Stroke Risk; Symptoms; Severity of Burden; Substrate): A Novel Approach to In-Depth Characterization (Rather than Classification) of Atrial Fibrillation

G. Lip, I. V. Van Gelder, G. Hindricks, 2020, Thrombosis and Haemostasis.

Cardioversion of atrial fibrillation and atrial flutter revisited: current evidence and practical guidance for a common procedure

Assessment of sex-related differences and outcome in patients who underwent cryoballoon pulmonary vein isolation for atrial fibrillation: an observational cohort study

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2022, BMJ Open.

Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation

P. Kirchhof, U. Schotten, I. V. Van Gelder, 2020, Heart.

Development of an international standard set of outcome measures for patients with atrial fibrillation: a report of the International Consortium for Health Outcomes Measurement (ICHOM) atrial fibrillation working group

I. V. Van Gelder, A. Banerjee, A. Bollmann, 2020, European heart journal.

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)

G. Lip, I. V. Van Gelder, A. Goette, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Asymptomatic persistent atrial fibrillation and outcome: results of the RACE study.

H. Crijns, I. V. Van Gelder, M. Rienstra, 2014, Heart rhythm.

Genetic aspects of atrial fibrillation.

I. V. Van Gelder, M. P. van den Berg, D. V. van Veldhuisen, 2005, Cardiovascular research.

Molecular mechanisms of remodeling in human atrial fibrillation.

Harry J G M Crijns, I. V. Van Gelder, H. Crijns, 2002, Cardiovascular research.

Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society

G. Lip, I. V. Van Gelder, B. Gorenek, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Lenient versus strict rate control in patients with atrial fibrillation.

Otto Kamp, Hans L Hillege, Jan G P Tijssen, 2010, The New England journal of medicine.

Verapamil reduces tachycardia-induced electrical remodeling of the atria.

M. Allessie, H. Crijns, I. V. Van Gelder, 1997, Circulation.

Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment.

H. Crijns, I. V. Van Gelder, H. Crijns, 1988, The American journal of cardiology.

Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm and amiodarone.

I. V. Van Gelder, H. Crijns, B. Schoonderwoerd, 2000, The American journal of cardiology.

Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.

I. V. Van Gelder, R. Tieleman, H. Crijns, 1999, The American journal of cardiology.

Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation.

H. Crijns, I. V. Van Gelder, R. Tieleman, 1996, Archives of internal medicine.

Prediction of uneventful cardioversion and maintenance of sinus rhythm from direct-current electrical cardioversion of chronic atrial fibrillation and flutter.

H. Crijns, I. V. Van Gelder, H. Crijns, 1991, The American journal of cardiology.

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

H. Crijns, I. V. Van Gelder, J. Tijssen, 2002, The New England journal of medicine.

I. V. Van Gelder, M. Rienstra, H. Crijns, 2005, Journal of the American College of Cardiology.

Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous system.

I. V. Van Gelder, A. Smit, H. Crijns, 2001, European heart journal.

Early or Delayed Cardioversion in Recent‐Onset Atrial Fibrillation

H. Crijns, I. V. Van Gelder, M. Rienstra, 2019, The New England journal of medicine.

Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure.

A. Capucci, I. V. Van Gelder, C. Lau, 2018, Journal of the American College of Cardiology.

Stroke risk in patients with device-detected atrial high-rate episodes

U. Schotten, I. V. Van Gelder, M. Rienstra, 2017, Netherlands Heart Journal.

Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT

A. Capucci, H. Crijns, I. V. Van Gelder, 2017, European heart journal.

Response to letter regarding article "Temporal relationship between subclinical atrial fibrillation and embolic events".

A. Capucci, I. V. Van Gelder, C. Lau, 2015, Circulation.

Temporal Relationship Between Subclinical Atrial Fibrillation and Embolic Events

A. Capucci, I. V. Van Gelder, J. Healey, 2014, Circulation.

Heart failure and atrial fibrillation: current concepts and controversies.

I. V. Van Gelder, H. Crijns, M. P. van den Berg, 1997, Heart.

In-hospital and 12-month follow-up outcome from the ESC-EORP EHRA Atrial Fibrillation Ablation Long-Term registry: sex differences.

L. Jordaens, I. V. Van Gelder, L. Tavazzi, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Initial experience with pulsed field ablation for atrial fibrillation

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2022, Frontiers in Cardiovascular Medicine.

Genetic Susceptibility for Atrial Fibrillation in Patients Undergoing Atrial Fibrillation Ablation

Jay A. Montgomery, M. Chung, I. V. Van Gelder, 2020, Circulation. Arrhythmia and electrophysiology.

Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation

I. V. Van Gelder, M. Rienstra, Y. Blaauw, 2019, Netherlands Heart Journal.

G. Lip, I. V. Van Gelder, A. Goette, 2017, European journal of preventive cardiology.

Planning and monitoring of patients for electrical cardioversion for atrial fibrillation

R. P. Vermeulen, I. V. Van Gelder, M. D. Smit, 2011, Netherlands Heart Journal.

Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.

G. Lip, I. V. Van Gelder, S. Hohnloser, 2010, Journal of the American College of Cardiology.

Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation

I. V. Van Gelder, F. Rutten, M. Rienstra, 2020, BMJ Open.

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference

G. Breithardt, A. Camm, P. Kirchhof, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

I. V. Van Gelder, A. Goette, E. Benjamin, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Incidence and outcome of atrial fibrillation: diversity throughout Europe

I. V. Van Gelder, M. Rienstra, 2021, European heart journal.

Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation

P. Kirchhof, U. Schotten, I. V. Van Gelder, 2018, European heart journal.

Screening for Atrial Fibrillation : a European Heart Rhythm Association ( EHRA ) consensus document endorsed by the Heart Rhythm Society ( HRS ) , Asia Pacific Heart Rhythm Society ( APHRS ) , and Societad Latinoamericana de Estimulation

G. Lip, I. V. Van Gelder, B. Gorenek, 2018 .

Acute cardioversion vs a wait‐and‐see approach for recent‐onset symptomatic atrial fibrillation in the emergency department: Rationale and design of the randomized ACWAS trial

I. V. Van Gelder, M. Rienstra, M. Prins, 2017, American heart journal.

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.

Hans L Hillege, Bastiaan Geelhoed, I. V. Van Gelder, 2015, Journal of the American College of Cardiology.

Rationale and current perspective for early rhythm control therapy in atrial fibrillation

E. Aliot, P. Kirchhof, I. V. Van Gelder, 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Time course of hemodynamic changes and improvement of exercise tolerance after cardioversion of chronic atrial fibrillation unassociated with cardiac valve disease.

H. Crijns, I. V. Van Gelder, H. Crijns, 1993, The American journal of cardiology.

Efficacy and safety of flecainide acetate in the maintenance of sinus rhythm after electrical cardioversion of chronic atrial fibrillation or atrial flutter.

I. V. Van Gelder, H. Crijns, K. Lie, 1989, The American journal of cardiology.

Role of inflammation in early atrial fibrillation recurrence.

I. V. Van Gelder, M. D. Smit, D. V. van Veldhuisen, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

The progressive nature of atrial fibrillation: a rationale for early restoration and maintenance of sinus rhythm.

I. V. Van Gelder, M. Hemels, 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria?

J Haaksma, M. Allessie, I. V. Van Gelder, 1998, Journal of the American College of Cardiology.

Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter.

H. Crijns, I. V. Van Gelder, H. Crijns, 1992, JAMA.

Molecular adaptations in human atrial fibrillation : mechanisms of protein remodeling

I. V. Van Gelder, H. Crijns, R. Henning, 2000 .

Paradigm shifts in pathophysiology and management of atrial fibrillation—a tale of the RACE trials in the Netherlands

H. Crijns, I. V. Van Gelder, H. Crijns, 2020, Netherlands Heart Journal.

Rate control in atrial fibrillation: many questions still unanswered.

I. V. Van Gelder, M. Rienstra, B. Mulder, 2015, Circulation.

Digoxin in patients with permanent atrial fibrillation: data from the RACE II study.

I. V. Van Gelder, M. Rienstra, J. Tijssen, 2014, Heart rhythm.

Surgical vs. transcatheter pulmonary vein isolation as first invasive treatment in patients with atrial fibrillation: a matched group comparison.

I. V. Van Gelder, M. Rienstra, Gijs E De Maat, 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post‐hoc analysis of the RACE II study

H. Crijns, I. V. Van Gelder, M. Rienstra, 2013, European journal of heart failure.

Ventricular rate control of atrial fibrillation in heart failure.

I. V. Van Gelder, M. Rienstra, 2013, Heart failure clinics.

Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey.

G. Lip, I. V. Van Gelder, J. Svendsen, 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

The importance of whether atrial fibrillation or heart failure develops first

I. V. Van Gelder, M. D. Smit, D. J. Veldhuisen, 2012, European journal of heart failure.

Contemporary Reviews in Cardiovascular Medicine Symptoms and Functional Status of Patients With Atrial Fibrillation State of the Art and Future Research Opportunities

I. V. Van Gelder, M. Rienstra, E. Benjamin, 2012 .

Atrial resynchronization therapy: a new concept for treatment of heart failure with preserved ejection fraction and prevention of atrial fibrillation?

I. V. Van Gelder, A. Maass, 2012, European journal of heart failure.

Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.

H. Crijns, I. V. Van Gelder, M. D. Smit, 2011, Journal of the American College of Cardiology.

Rate Control in Atrial Fibrillation.

I. V. Van Gelder, H. Groenveld, Hessel F. Groenveld, 2010, Cardiac electrophysiology clinics.

Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.

H. Crijns, I. V. Van Gelder, M. Rienstra, 2009, American heart journal.

Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study.

I. V. Van Gelder, A. Ranchor, A. Pilmeyer, 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Management of atrial fibrillation in patients with heart failure.

M. Allessie, U. Schotten, I. V. Van Gelder, 2007, European heart journal.

Induction of Heat Shock Response Protects the Heart Against Atrial Fibrillation

I. V. Van Gelder, R. Henning, H. Kampinga, 2006, Circulation research.

Does intensity of rate-control influence outcome in atrial fibrillation? An analysis of pooled data from the RACE and AFFIRM studies.

H. Crijns, I. V. Van Gelder, D. Wyse, 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study.

H. Crijns, I. V. Van Gelder, M. Rienstra, 2006, The American journal of cardiology.

Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.

I. V. Van Gelder, H. Crijns, M. P. van den Berg, 2006, Journal of the American College of Cardiology.

Rhythm control strategies for symptomatic atrial fibrillation

I. V. Van Gelder, M. P. van den Berg, D. V. van Veldhuisen, 2007 .

A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival.

I. V. Van Gelder, M. Rienstra, M. P. van den Berg, 2006, International journal of cardiology.

Implication from Randomized Trials of Rate and Rhythm Controls on Management of Patients with Persistent Atrial Fibrillation

H. Crijns, I. V. Van Gelder, D. V. van Veldhuisen, 2006, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

Ablation for atrial fibrillation in congestive heart failure.

H. Crijns, I. V. Van Gelder, R. Tieleman, 2005, The New England journal of medicine.

Rate control in atrial fibrillation.

I. V. Van Gelder, M. Rienstra, M. P. van den Berg, 2004, Journal of the American College of Cardiology.

Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.

H. Crijns, I. V. Van Gelder, J. Tijssen, 2004, European heart journal.

The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.

H. Crijns, I. V. Van Gelder, V. Hagens, 2003, Cardiac electrophysiology review.

Obesity is associated with impaired long-term success of pulmonary vein isolation: a plea for risk factor management before ablation

I. V. Van Gelder, M. Rienstra, Y. Blaauw, 2018, Open Heart.

Randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of a single oral dose of vanoxerine for the conversion of subjects with recent onset atrial fibrillation or flutter to normal sinus rhythm: RESTORE SR.

Gary Koch, Laura E Wiener, G. Koch, 2016, Heart rhythm.

Effectiveness and safety of dabigatran versus acenocoumarol in ‘real-world’ patients with atrial fibrillation

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Surgical Left Atrial Appendage Exclusion Does Not Impair Left Atrial Contraction Function: A Pilot Study

I. V. Van Gelder, S. Benussi, Gijs E De Maat, 2015, BioMed research international.

New oral anticoagulants in heart failure

G. Lip, I. V. Van Gelder, D. V. van Veldhuisen, 2013, European journal of heart failure.

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation.

A. Capucci, I. V. Van Gelder, S. Hohnloser, 2011, Journal of the American College of Cardiology.

Distribution of Cardioembolic Stroke: A Cohort Study

I. V. Van Gelder, A. Algra, E. V. van Dijk, 2020, Cerebrovascular Diseases.

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference

U. Schotten, I. V. Van Gelder, G. Hindricks, 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations

I. V. Van Gelder, M. Rienstra, E. Benjamin, 2016, PloS one.

Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation.

H. Crijns, I. V. Van Gelder, D. V. van Veldhuisen, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Epidemiology and modifiable risk factors for atrial fibrillation

I. V. Van Gelder, C. Albert, P. Sanders, 2023, Nature Reviews Cardiology.

Risk Factors for Atrial Fibrillation Progression.

H. Crijns, I. V. Van Gelder, J. Heijman, 2021, Cardiac electrophysiology clinics.

The Present and FutureReview Topic of the WeekHeart Failure With Preserved Ejection Fraction and Atrial Fibrillation: Vicious Twins

Dipak Kotecha, I. V. Van Gelder, M. Rienstra, 2016 .

Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation.

I. V. Van Gelder, R. Tieleman, H. Crijns, 1999, Cardiovascular research.

Cyclical stretch induces structural changes in atrial myocytes

I. V. Van Gelder, R. D. de Boer, W. V. van Gilst, 2013, Journal of cellular and molecular medicine.

Alterations in potassium channel gene expression in atria of patients with persistent and paroxysmal atrial fibrillation: differential regulation of protein and mRNA levels for K+ channels.

H. Crijns, I. V. Van Gelder, H. Crijns, 2001, Journal of the American College of Cardiology.

Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation.

I. V. Van Gelder, H. Crijns, M. P. van den Berg, 2005, Progress in cardiovascular diseases.

Lone atrial fibrillation: does it exist?

U. Schotten, I. V. Van Gelder, M. Rienstra, 2014, Journal of the American College of Cardiology.

Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial

H. Crijns, I. V. Van Gelder, M. D. Smit, 2018, European heart journal.

Atrial Ultrastructural Changes During Experimental Atrial Tachycardia Depend on High Ventricular Rate

H. Crijns, I. V. Van Gelder, D. V. van Veldhuisen, 2004, Journal of cardiovascular electrophysiology.

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure: background, aims and design of the RACE 3 study

H. Crijns, I. V. Van Gelder, M. D. Smit, 2013, Netherlands Heart Journal.

An entirely subcutaneous implantable cardioverter-defibrillator.

Alexander H Maass, Johannes Sperzel, Riccardo Cappato, 2010, The New England journal of medicine.

Left ventricular beat-to-beat performance in atrial fibrillation: contribution of Frank-Starling mechanism after short rather than long RR intervals.

H. Crijns, I. V. Van Gelder, H. Crijns, 1995, Journal of the American College of Cardiology.

University of Groningen Atrial Remodeling Is Directly Related to End-Diastolic Left Ventricular Pressure in a Mouse Model of Ventricular Pressure Overload

I. V. Van Gelder, W. V. van Gilst, I. Gelder, 2013 .

Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?

M. Allessie, H. Crijns, I. V. Van Gelder, 2005, Heart rhythm.

New treatment options for atrial fibrillation: towards patient tailored therapy

I. V. Van Gelder, M. D. Smit, Isabelle C Van Gelder, 2011, Heart.

Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up.

I. V. Van Gelder, M. Rienstra, 2006, European heart journal.

Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter.

I. V. Van Gelder, H. Crijns, H. Hillege, 1991, The American journal of cardiology.

Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens.

I. V. Van Gelder, H. Crijns, K. Lie, 1988, European heart journal.

Female sex as an independent risk factor for stroke in atrial fibrillation: Possible mechanisms

I. V. Van Gelder, C. Albert, E. Hylek, 2013, Thrombosis and Haemostasis.

Beta-blockers and outcome in heart failure and atrial fibrillation: a meta-analysis.

I. V. Van Gelder, M. Rienstra, J. McMurray, 2013, JACC. Heart failure.

Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS

I. V. Van Gelder, A. Cohen-Solal, D. J. Veldhuisen, 2012, European journal of heart failure.

Stroke aetiology in heart failure: towards patient‐tailored prevention of stroke

I. V. Van Gelder, P. Kamphuisen, B. Mulder, 2012, European journal of heart failure.

Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design.

I. V. Van Gelder, J. Tijssen, H. Crijns, 2002, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Rhythm control for atrial fibrillation: non-channel antiarrhythmic drugs are en vogue.

I. V. Van Gelder, 2007, Cardiovascular research.

Relevance of Electrical Remodeling in Human Atrial Fibrillation: Results of the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial Mechanisms of Atrial Fibrillation Study

A. Capucci, I. V. Van Gelder, C. Lau, 2012, Circulation. Arrhythmia and electrophysiology.

Stroke type and severity in patients with subclinical atrial fibrillation: An analysis from the Asymptomatic Atrial Fibrillation and Stroke Evaluation in Pacemaker Patients and the Atrial Fibrillation Reduction Atrial Pacing Trial (ASSERT)

A. Capucci, I. V. Van Gelder, C. Lau, 2018, American heart journal.

Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension.

I. V. Van Gelder, R. Tieleman, H. Crijns, 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference.

A. Camm, P. Kirchhof, G. Lip, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Does myocardial infarction beget atrial fibrillation and atrial fibrillation beget myocardial infarction?

I. V. Van Gelder, M. Rienstra, H. Crijns, 2015, Circulation.

Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial

I. V. Van Gelder, A. Algra, G. Rinkel, 2015, Trials.

Corrigendum to: AV junction ablation and cardiac resynchronization for patients with permanent atrial fibrillation and narrow QRS: the APAF-CRT mortality trial.

I. V. Van Gelder, M. Rienstra, L. Fauchier, 2021, European heart journal.

A family with Andersen-Tawil syndrome and dilated cardiomyopathy.

I. V. Van Gelder, A. Wilde, M. P. van den Berg, 2006, Heart rhythm.

EHRA White Paper: knowledge gaps in arrhythmia management-status 2019.

A. Camm, I. V. Van Gelder, G. Hindricks, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy

I. V. Van Gelder, M. D. Smit, H. Hillege, 2011, European journal of heart failure.

Right Heart Dysfunction in Heart Failure With Preserved Ejection Fraction: The Impact of Atrial Fibrillation.

I. V. Van Gelder, M. Rienstra, A. Voors, 2017, Journal of cardiac failure.

Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.

Stephen L Moore, I. V. Van Gelder, B. Wilkoff, 2008, Journal of the American College of Cardiology.

Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma.

I. V. Van Gelder, M. Rienstra, J. Burgerhof, 2015, The Journal of clinical endocrinology and metabolism.

Myocardial perfusion imaging does not adequately assess the risk of coronary artery disease in patients with atrial fibrillation.

I. V. Van Gelder, M. D. Smit, F. Zijlstra, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.

I. V. Van Gelder, H. Crijns, P. Kułakowski, 2006, Heart rhythm.

Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.

I. V. Van Gelder, H. Crijns, H. Crijns, 2000, European heart journal.

Lack of prevention of heart failure by serial electrical cardioversion in patients with persistent atrial fibrillation

I. V. Van Gelder, H. Crijns, P. De Kam, 1999, Heart.

Incidence and clinical significance of ST segment elevation after electrical cardioversion of atrial fibrillation and atrial flutter.

I. V. Van Gelder, H. Crijns, A. Van der Laarse, 1991, American heart journal.

Effects of flecainide on the atrial defibrillation threshold.

I. V. Van Gelder, H. Crijns, K. Lie, 1989, The American journal of cardiology.

Human SCN5A gene mutations alter cardiac sodium channel kinetics and are associated with the Brugada syndrome.

I. V. Van Gelder, A. Wilde, M. Rook, 1999, Cardiovascular research.

Symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study.

I. V. Van Gelder, M. Rienstra, J. Tijssen, 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Lifestyle components: Self-reported physical activity, nutritional status, sleep quality and incident atrial fibrillation

I. V. Van Gelder, M. Rienstra, R. D. de Boer, 2020, International journal of cardiology. Heart & vasculature.

Atrial fibrillation in acute heart failure: A position statement from the Acute Cardiovascular Care Association and European Heart Rhythm Association of the European Society of Cardiology

I. V. Van Gelder, T. Potpara, H. Bueno, 2020, European heart journal. Acute cardiovascular care.

Effects of a simple cardiac rehabilitation program on improvement of self-reported physical activity in atrial fibrillation – Data from the RACE 3 study

I. V. Van Gelder, M. D. Smit, B. Nguyen, 2020, International journal of cardiology. Heart & vasculature.

Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not?

I. V. Van Gelder, M. Gheorghiade, D. V. van Veldhuisen, 2013, European heart journal.

Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF

G. Breithardt, H. Crijns, P. Mclaughlin, 2016, Journal of the American Heart Association.

Incidence of paroxysmal atrial tachycardias in patients treated with cardiac resynchronization therapy and continuously monitored by device diagnostics.

J. Daubert, I. V. Van Gelder, C. Leclercq, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Identifying patients with atrial fibrillation recurrences after two pulmonary vein isolation procedures

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2021, Open Heart.

Atrial fibrillation progression risk factors and associated cardiovascular outcome in well-phenotyped patients: data from the AF-RISK study.

Still many unanswered questions about rate control therapy in atrial fibrillation

I. V. Van Gelder, M. Kloosterman, 2016, Evidence-Based Medicine.

ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the atrial fibrillation Reduction atrial pacing Trial (ASSERT).

A. Capucci, I. V. Van Gelder, C. Lau, 2012, American heart journal.

Comparing biomarker profiles of patients with heart failure: atrial fibrillation vs. sinus rhythm and reduced vs. preserved ejection fraction

I. V. Van Gelder, P. Ponikowski, M. Rienstra, 2018, European heart journal.

Comparison of strain parameters in dyssynchronous heart failure between speckle tracking echocardiography vendor systems

I. V. Van Gelder, M. Rienstra, K. Vernooy, 2017, Cardiovascular Ultrasound.

Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study

H. Crijns, U. Schotten, I. V. Van Gelder, 2023, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.

I. V. Van Gelder, M. Rienstra, R. D. de Boer, 2017, JACC. Heart failure.

The role of cardiologists in stroke prevention and treatment: position paper of the European Society of Cardiology Council on Stroke

I. V. Van Gelder, H. Diener, M. Mazighi, 2018, European heart journal.

Segment length in cine (SLICE) strain analysis: a practical approach to estimate potential benefit from cardiac resynchronization therapy

I. V. Van Gelder, M. Rienstra, K. Vernooy, 2021, Journal of Cardiovascular Magnetic Resonance.

Atrial overdrive pacing to prevent atrial fibrillation: insights from ASSERT.

A. Capucci, I. V. Van Gelder, C. Lau, 2012, Heart rhythm.

Pulmonary vein anatomy addressed by computed tomography and relation to success of second‐generation cryoballoon ablation in paroxysmal atrial fibrillation

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2019, Clinical cardiology.

Efficacy of serial electrical cardioversion therapy in patients with chronic atrial fibrillation after valve replacement and implications for surgery to cure atrial fibrillation.

I. V. Van Gelder, H. Crijns, R. Tieleman, 1996, The American journal of cardiology.

Brady- and tachyarrhythmias detected by continuous rhythm monitoring in paroxysmal atrial fibrillation

H. Crijns, U. Schotten, I. V. Van Gelder, 2023, Heart.

Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).

I. V. Van Gelder, J. Tijssen, H. Crijns, 2013, Journal of the American College of Cardiology.

RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.

I. V. Van Gelder, M. Rienstra, J. Tijssen, 2006, American heart journal.

Tissue velocity imaging of the left atrium predicts response to flecainide in patients with acute atrial fibrillation.

U. Schotten, I. V. Van Gelder, R. Tieleman, 2014, Heart rhythm.

Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias.

I. V. Van Gelder, B. Mulder, B. Bouma, 2013, The American journal of cardiology.

The cost of illness of atrial fibrillation: a systematic review of the recent literature.

I. V. Van Gelder, S. Wolowacz, V. Brennan, 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International Collaboration

Thalia Shoshana Field, A. Camm, P. Kirchhof, 2022, Circulation.

ESC and EHRA lead a path towards integrated care for multimorbid atrial fibrillation patients: the Horizon 2020 EHRA-PATHS project.

I. V. Van Gelder, H. Heidbuchel, L. Desteghe, 2021, European heart journal.

Cardiac electrophysiologic properties of intravenous isradipine in patients with sick sinus syndrome.

I. V. Van Gelder, H. Crijns, K. Lie, 1989, The American journal of medicine.

Electrophysiological Properties of Isradipine (PN200–110) in Humans

I. V. Van Gelder, K. Lie, H. Crijns, 1989, Journal of cardiovascular pharmacology.

The Value and Limitations of a Wound Inspection Clinic After Cardiac Device Implantation

I. V. Van Gelder, M. D. Smit, F. Zijlstra, 2009, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

Searching for atrial fibrillation: looking harder, looking longer, and in increasingly sophisticated ways. An EHRA position paper'.

I. V. Van Gelder, G. Boriani, G. Mairesse, 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial

G. Breithardt, H. Crijns, P. Kirchhof, 2021, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Temporal patterns and short-term progression of paroxysmal atrial fibrillation: data from RACE V

U. Schotten, I. V. Van Gelder, B. Nguyen, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) study

I. V. Van Gelder, M. Rienstra, F. Prinzen, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Nurse-led vs. usual-care for atrial fibrillation.

H. Crijns, I. V. Van Gelder, M. Rienstra, 2019, European heart journal.

Long-term outcome of electrical cardioversion in patients with chronic atrial flutter.

I. V. Van Gelder, H. Crijns, R. Tieleman, 1997, Heart.

Atrial flutter can be terminated by a class III antiarrhythmic drug but not by a class IC drug.

H. Crijns, I. V. Van Gelder, H. Crijns, 1994, European heart journal.

Atrial fibrillation detected at screening is not a benign condition: outcomes in screen-detected versus clinically detected atrial fibrillation. Results from the Prevention of Renal and Vascular End-stage Disease (PREVEND) study

I. V. Van Gelder, M. Rienstra, R. D. de Boer, 2021, Open Heart.

Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study.

Predictors of recurrence of atrial fibrillation within the first 3 months after ablation

Ethnic differences in atrial fibrillation among patients with heart failure in Asia

I. V. Van Gelder, M. Rienstra, W. Tay, 2020, ESC heart failure.

Prevalence and Incidence of Atrial Fibrillation in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: (Additive) Value of Implantable Loop Recorders

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2023, Journal of clinical medicine.

Newly discovered atrial fibrillation: who(se) care(s)?

I. V. Van Gelder, H. Crijns, N. Pluymaekers, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Effect of Systemic Hypertension With Versus Without Left Ventricular Hypertrophy on the Progression of Atrial Fibrillation (from the Euro Heart Survey).

G. Breithardt, A. Camm, A. Capucci, 2018, The American journal of cardiology.

Clinical, biomarker, and genetic predictors of specific types of atrial fibrillation in a community‐based cohort: data of the PREVEND study

I. V. Van Gelder, M. Rienstra, P. van der Harst, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Targeted therapy of underlying conditions improves quality of life in patients with persistent atrial fibrillation: results of the RACE 3 study.

I. V. Van Gelder, M. D. Smit, M. Rienstra, 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Optimal treatment of underlying conditions improves rhythm control outcome in atrial fibrillation - Data from RACE 3.

I. V. Van Gelder, M. D. Smit, B. Nguyen, 2020, American heart journal.

Surgical Minimally Invasive Pulmonary Vein Isolation for Lone Atrial Fibrillation

I. V. Van Gelder, O. Alfieri, S. Benussi, 2013, Innovations.

Recurrence of atrial fibrillation and the need for new definitions.

I. V. Van Gelder, H. Crijns, T. van Noord, 2001, European heart journal.

Clinical and electrophysiological predictors of device-detected new-onset atrial fibrillation during 3 years after cardiac surgery

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

H. Crijns, I. V. Van Gelder, O. Kamp, 2002 .

Atrial fibrillation and heart failure temporality: does it matter?

I. V. Van Gelder, M. Rienstra, C. van Deutekom, 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Corrigendum to: ‘Guidelines for the management of atrial fibrillation’ [European Heart Journal (2010) 31, 2369–2429 and EP-Europace (2010) 12, 1360–1420]

Ottavio Alfieri, Ulrich Schotten, Piotr Ponikowski, 2011 .

Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE).

I. V. Van Gelder, B. Gorenek, M. Rosenqvist, 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Management of atrial fibrillation in patients with heart failure.

M. Allessie, U. Schotten, I. V. Van Gelder, 2007, European heart journal.

Rhythm control for atrial fibrillation: non-channel antiarrhythmic drugs are en vogue.

I. V. Van Gelder, 2007, Cardiovascular research.

Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation

I. V. Van Gelder, H. Crijns, M. P. van den Berg, 2005, BMC cardiovascular disorders.

Estimated incidence of previously undetected atrial fibrillation on a 14-day continuous electrocardiographic monitor and associated risk of stroke.

I. V. Van Gelder, S. Connolly, M. Gold, 2022, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

New-onset perioperative atrial fibrillation in cardiac surgery patients: transient trouble or persistent problem?—Authors’ reply

HRS white paper on atrial fibrillation centers of excellence: Rationale, considerations, and goals.

I. V. Van Gelder, M. Turakhia, M. Hills, 2020, Heart rhythm.

Subclinical atherosclerosis is associated with incident atrial fibrillation: a systematic review and meta-analysis.

I. V. Van Gelder, A. Brandes, M. Rienstra, 2020, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Is inflammation a risk factor for recurrent atrial fibrillation?

I. V. Van Gelder, M. D. Smit, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Strain imaging to predict response to cardiac resynchronization therapy: a systematic comparison of strain parameters using multiple imaging techniques

I. V. Van Gelder, M. Rienstra, P. Croisille, 2018, ESC heart failure.

Case of the month by the EHRA Education committee: exercise-related arrhythmias.

S. Ernst, I. V. Van Gelder, H. Heidbuchel, 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Atrial disease and heart failure: the common soil hypothesis proposed by the Heart Failure Association of the European Society of Cardiology.

I. V. Van Gelder, G. Hindricks, P. Ponikowski, 2021, European heart journal.

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.

I. V. Van Gelder, L. Fauchier, L. Neubeck, 2021, European journal of preventive cardiology.

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

U. Schotten, I. V. Van Gelder, B. Gorenek, 2016, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

Jeroen J. Bax, Gerhard Hindricks, Paulus Kirchhof, 2012, European heart journal.

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference.

G. Breithardt, P. Kirchhof, U. Schotten, 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

I. V. Van Gelder, B. Wilkoff, M. Wathen, 2008, Journal of the American College of Cardiology.

Atrial Remodeling Is Directly Related to End-Diastolic Left Ventricular Pressure in a Mouse Model of Ventricular Pressure Overload

I. V. Van Gelder, W. V. van Gilst, M. Cannon, 2013, PloS one.

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

Gerhard Hindricks, Paulus Kirchhof, Gregory Y H Lip, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Multimorbid management in atrial fibrillation: The Polish perspective in the EHRA-PATHS study.

I. V. Van Gelder, H. Heidbuchel, M. Rienstra, 2023, Kardiologia polska.

Predictors of non-pharmacological intervention in patients with paroxysmal atrial fibrillation: Value of neuroticism.

I. V. Van Gelder, M. P. van den Berg, D. V. van Veldhuisen, 2006, International journal of cardiology.

Cardiovascular and renal multimorbidity increase risk of atrial fibrillation in the PREVEND cohort

I. V. Van Gelder, M. Rienstra, B. V. van Munster, 2023, Open Heart.

Lenient vs. strict rate control in patients with atrial fibrillation and heart failure: a post‐hoc analysis of the RACE II study

H. Crijns, I. V. Van Gelder, M. Rienstra, 2013, European journal of heart failure.

Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.

H. Crijns, I. V. Van Gelder, M. Rienstra, 2008, JAMA.

Rate control in atrial fibrillation, calcium channel blockers versus beta-blockers

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2023, Heart.

Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation.

The clinical value of regular thyroid function tests during amiodarone treatment.

I. V. Van Gelder, M. Rienstra, S. Benjamens, 2017, European journal of endocrinology.

Pulmonary vein anatomy addressed by computed tomography and relation to success of second‐generation cryoballoon ablation in paroxysmal atrial fibrillation

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2019, Clinical cardiology.

Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality: A Community-Based Study From the Netherlands.

I. V. Van Gelder, M. Rienstra, R. Tieleman, 2015, Journal of the American College of Cardiology.

Multimorbidity in patients with atrial fibrillation

I. V. Van Gelder, M. Rienstra, M. Middeldorp, 2024, Open heart.

Telomere length and incident atrial fibrillation – data of the PREVEND cohort

I. V. Van Gelder, M. Rienstra, P. van der Harst, 2017, PloS one.

Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference

I. V. Van Gelder, M. Rienstra, H. Puererfellner, 2024, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Jeroen J. Bax, U. Schotten, I. Savelieva, 2012, European heart journal.

Clinical Trials on Atrial Fibrillation/Future Perspectives

A. Camm, P. Kirchhof, I. V. Van Gelder, 2011 .